Pictet-Biotech R USD LU0112497440 · Fund Open Pictet-Biotech R USD in new tab

1172.15 USD

Add to portfolio

Beta

0.96

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

Pictet-Biotech R USD Analysis (LU0112497440)

Unknown Fund

Investment Objective: Pictet-Biotech R USD is an investment vehicle in Unknown. It is currently trading at 1172.15 USD.

Income: This appears to be an accumulating fund (dividends are reinvested) or focuses purely on capital growth.

Investor FAQ

Does Pictet-Biotech R USD pay a dividend?

No, it does not currently pay a dividend.

What asset class is Pictet-Biotech R USD?

Pictet-Biotech R USD is classified as a Fund. You can compare it against its peer in the "Related Symbols" list.

Fund Strategy

No detailed summary available for Pictet-Biotech R USD.

Exchange Ticker

LU0112497440

Trades

No dividend information available for this instrument.

2026 © AllInvestView

Twitter YouTube Reddit Feature Requests Changelog Support Pricing Help

Support email: [email protected]

Terms of Service | Privacy Policy

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.